Inicio › Glioblastoma › Carolina del Norte › Durham
Ensayos clínicos de Glioblastoma en Durham, NC
20 estudios para Glioblastoma buscan participantes en centros de Durham y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
ReclutandoFase 3
- University of North Carolina, Chapel Hill · A 10 mi de distancia
Targeted Pediatric High-Grade Glioma Therapy
ReclutandoEstudio observacional
- Duke University Health System, Durham
Study of Olutasidenib and Temozolomide in HGG
ReclutandoFase 2
- Duke University Health System, Durham
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
ReclutandoFase 3
- Duke Cancer Institute, Durham
BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma
ReclutandoFase 1
- Duke University Medical Center, Durham
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
ReclutandoFase 2
- Duke University Medical Center, Durham
A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
ReclutandoFase 2
- Duke University, Durham
A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
ReclutandoFase 2
- Duke University, Durham
Lerapolturev (PVSRIPO) in GBM
ReclutandoFase 2
- Duke University Medical Center, Durham
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
ReclutandoFase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · A 10 mi de distancia
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
ReclutandoFase 1 tempranaSe aceptan voluntarios sanos
- Duke University Health System, Durham
Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma
ReclutandoFase 1
- Duke University Medical Center, Durham
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
ReclutandoFase 2
- Duke University Health System, Durham
Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
ReclutandoFase 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · A 10 mi de distancia
Key Longitudinal Associations With Risk and Glioblastoma Outcomes
ReclutandoEstudio observacional
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Chapel Hill · A 10 mi de distancia
D2C7-IT + 2141-V11 Combination Post-resection in rGBM
ReclutandoFase 1
- Duke University Medical Center, Durham
D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
ReclutandoFase 1/2
- Duke University Medical Center, Durham
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
ReclutandoFase 2
- University of North Carolina, Chapel Hill · A 10 mi de distancia
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
ReclutandoFase 1
- Duke University, Durham
Ensayos de Glioblastoma en otras ciudades
- New York City, NY30 estudios
- Boston, MA28 estudios
- Houston, TX26 estudios
- Los Angeles, CA24 estudios
- San Francisco, CA17 estudios
- Chicago, IL15 estudios
- Washington, DC15 estudios
- Miami, FL14 estudios
- Columbus, OH14 estudios
- Rochester, MN13 estudios
- Jacksonville, FL13 estudios
- Aurora, CO12 estudios
Otros estudios en Durham
- Cáncer de seno64 estudios
- Cáncer (todos los tipos)58 estudios
- Cáncer de pulmón de células no pequeñas39 estudios
- Mieloma múltiple37 estudios
- Leucemia mielógena aguda33 estudios
- Cáncer metastásico33 estudios
- Cáncer de próstata32 estudios
- Cáncer de pulmón32 estudios
- Cáncer del colon y del recto28 estudios
- Cáncer de ovario27 estudios
- Leucemia linfocítica crónica27 estudios
- Fallo cardíaco26 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.